title: [Multiple sclerosis: new drugs and their molecular targets].
authors.affiliation: Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University.
authors.forename: Takahide
authors.initials: T
authors.lastname: Itokazu
authors.forename: Toshihide
authors.initials: T
authors.lastname: Yamashita
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Takahashi
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068876:Fingolimod Hydrochloride; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D011409:Propylene Glycols / Q000627:therapeutic use; D013110:Sphingosine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine